SLC38A12 Knockout HCT 116 Cell Line
Cat.No.:
EDC07780
Species:
Human
Cell Name:
HCT 116
Gene:
SLC38A12
Gene ID:
54868
Size:
1×10⁶cells
TMEM104 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07780 |
|---|---|
| Product Name | TMEM104 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Gene ID | |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC38A12 |
| Gene Synonyms | SLC38A12 |
| Summary |
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
|
| Digestion Time | 3 min |
| Associated Diseases | Colorectal Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC38A12 function, SLC38A12 Knockout HCT 116 Cell Line or SLC38A12 overexpression HCT 116 Cell Line?
The choice depends on the experimental question, but for SLC38A12 — an emerging factor — the framing of the question itself often needs to come first. SLC38A12 belongs to the SLC38/SNAT family of sodium-coupled neutral amino acid transporters but is comparatively less characterized than SNAT1-5 and SNAT7. Predicted to function as an amino acid transporter, but the substrate specificity, sodium-coupling, and cellular function require empirical determination.
The EDITGENE Knockout in HCT 116 is most useful for unbiased discovery — characterizing transcriptomic and metabolomic consequences of SLC38A12 loss in a colorectal cancer background to identify candidate substrates and functions. Discovery-oriented approaches (metabolomics with broad amino acid panel, transcriptomics) in the knockout are most informative at this stage. Rescue with wild-type SLC38A12 serves as the specificity control during phenotypic characterization.
What are the application scenarios for this model?
Primary applications:
• Discovery transcriptomics: RNA-seq to characterize gene expression changes in the knockout, generating hypotheses for an under-characterized SLC38 family member.
• Amino acid metabolomics: broad amino acid panel analysis under nutrient-replete and depleted conditions to identify candidate substrates.
• Phenotypic profiling: proliferation, viability, and amino acid starvation response characterization.
• Heterologous expression: rescue with epitope-tagged SLC38A12 for subcellular localization and interactome studies.
EDITGENE recommends this model as a starting platform for functional characterization of SLC38A12, given its limited prior characterization in published literature.
Is this SLC38A12 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes, and rescue experiments are particularly important for this under-characterized factor:
• Construct design: use a codon-modified SLC38A12 sequence with a small C-terminal tag (FLAG, HA). The predicted SLC38 family transmembrane architecture should be preserved.
• Discovery-oriented rescue: parallel wild-type rescue during phenotypic characterization distinguishes true SLC38A12-dependent phenotypes from off-target editing artifacts — critical for emerging factors.
• Localization validation: confirm subcellular localization of exogenous protein by imaging given limited prior data.
• Functional readout: rescue should restore phenotypes identified in discovery transcriptomics or metabolomics analyses; amino acid uptake panels test the predicted SLC38 family activity.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download